The EPS projection of Rosetta Stone (NYSE:RST) for quarter ended 2016-09-30 is $-0.55. Last week, the EPS forecast was $-0.55 against target of $-0.55, a month earlier. Two months ago, this estimate was $-0.55 versus forecast of $-0.55 three months earlier, implying a deviation of 0%.
Rosetta Stone (NYSE:RST) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Rosetta Stone (NYSE:RST) in the preceding 30, 120, 60 and 90 days were 0, 1, 2, and 2, correspondingly.
Rosetta Stone (NYSE:RST) EPS target for the quarter closed 1 was $-0.55, based on 2 recommendations. As reported on 2016-05-04 the EPS was $-0.22. The change was $0.3, implying a percentage deviation of 57.69%. The projections showed a standard deviation of 0.03.
Quarterly Sales Estimates
Rosetta Stone (NYSE:RST) yearly sales prediction for the fiscal 2016 stands at $49.06 and the median estimate is at $49.06. Almost 2 analysts issued sales target.
Highest sales target is $49.5 while the lowest target is $48.62 showing standard deviation of 0.622%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Rosetta Stone (NYSE:RST) announced that the deviation in forecast was -9.181%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...